NO20004583D0 - Krystallinsk form av paroxetine - Google Patents

Krystallinsk form av paroxetine

Info

Publication number
NO20004583D0
NO20004583D0 NO20004583A NO20004583A NO20004583D0 NO 20004583 D0 NO20004583 D0 NO 20004583D0 NO 20004583 A NO20004583 A NO 20004583A NO 20004583 A NO20004583 A NO 20004583A NO 20004583 D0 NO20004583 D0 NO 20004583D0
Authority
NO
Norway
Prior art keywords
paroxetine
crystalline form
crystalline
Prior art date
Application number
NO20004583A
Other languages
English (en)
Other versions
NO20004583L (no
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaine
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20004583D0 publication Critical patent/NO20004583D0/no
Publication of NO20004583L publication Critical patent/NO20004583L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
NO20004583A 1998-03-16 2000-09-14 Krystallinsk form av paroxetine NO20004583L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (2)

Publication Number Publication Date
NO20004583D0 true NO20004583D0 (no) 2000-09-14
NO20004583L NO20004583L (no) 2000-09-15

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004583A NO20004583L (no) 1998-03-16 2000-09-14 Krystallinsk form av paroxetine

Country Status (18)

Country Link
EP (1) EP1064282A1 (no)
JP (1) JP2002506865A (no)
KR (1) KR20010041947A (no)
CN (1) CN1300286A (no)
AP (1) AP2000001907A0 (no)
AU (1) AU2847199A (no)
BG (1) BG104839A (no)
BR (1) BR9908825A (no)
CA (1) CA2323896A1 (no)
EA (1) EA200000946A1 (no)
HU (1) HUP0101215A3 (no)
ID (1) ID27596A (no)
IL (1) IL138390A0 (no)
NO (1) NO20004583L (no)
PL (1) PL342931A1 (no)
SK (1) SK13622000A3 (no)
TR (1) TR200002675T2 (no)
WO (1) WO1999047519A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion

Also Published As

Publication number Publication date
SK13622000A3 (sk) 2001-03-12
CA2323896A1 (en) 1999-09-23
KR20010041947A (ko) 2001-05-25
HUP0101215A3 (en) 2002-05-28
PL342931A1 (en) 2001-07-16
CN1300286A (zh) 2001-06-20
EA200000946A1 (ru) 2001-02-26
BR9908825A (pt) 2000-11-21
AP2000001907A0 (en) 2000-09-30
AU2847199A (en) 1999-10-11
JP2002506865A (ja) 2002-03-05
HUP0101215A2 (hu) 2002-04-29
BG104839A (en) 2001-09-28
TR200002675T2 (tr) 2000-12-21
IL138390A0 (en) 2001-10-31
WO1999047519A1 (en) 1999-09-23
NO20004583L (no) 2000-09-15
ID27596A (id) 2001-04-12
EP1064282A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
ID29021A (id) Komposisi galantamina pelepasan terkontrol
ID27092A (id) Pembuatan ftalat anhidrida
DE60038481D1 (de) Kristalline form des (r)-2-äää3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridinylümethylüsulfinylü-1h-benzimidazols
NO20011083L (no) Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
PT945132E (pt) Composicao de ibuprofeno
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
DE60000003T2 (de) Paroxetinmethansulfonat
NO20010899D0 (no) Forbedring av ugunstige apomorfin-effekter
IS2019B (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
NO20020030D0 (no) Krystallinske 1-metylcarbapenemforbindelser
NO993460D0 (no) Paroxetine-preparater
ATE282038T1 (de) Kristallin form ii von cabergolin
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20010553L (no) Krystallinske former av osanetant
NO20003960D0 (no) Salter av paroksetin
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO20006547D0 (no) Salter av paroxetine
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
NO20013857D0 (no) Krystallinsk form av Eplerenon
NO20004583D0 (no) Krystallinsk form av paroxetine
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
EE200100381A (et) Morfolinobensamiidi uued soolad
PT1175417E (pt) Compostos substituidos de benzolactamas
DE59907344D1 (de) Feinteiliges kristallines Natriumdisilikat
PT1232141E (pt) Eteres de o-desmetil-venlafaxina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application